P/B
40,9
NeuroPace
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
$485.7M
Market Cap • 9/28/2026
1997
(29 years)
Founded
2021
(5 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
4,9
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
0,4
EPS
—
Market Cap
Market Cap
485,7M
EV
503,9M
EV/Revenue
5,1
EV/EBITDA
-38,7
EV/EBIT
-33,4
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-0,3%
Total Yield
-0,3%
Payout
0%
Retained Earnings
-565,3M
Profitability
Gross Margin
79,6%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
28%
Capex/Revenue
0,4%
Capex/D&A
18%
Capex/OCF
-3,3%
SBC/OCF
—
% PPE
10,8%
% Goodwill
0%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
15,8%
CAGR Op. Income 5Y
3,6%
CAGR Net Income 5Y
-6,1%
CAGR EPS 5Y
-62,3%
CAGR OCF 5Y
-13,9%
Leverage
N.D./EBITDA
—
Debt/Equity
0%
Current Ratio
4,9
Quick Ratio
3,8
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!